ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions
View by Date

Tuesday, November 12, 2019

9:00AM-11:00AM
Abstract Number: 2612
Minocycline for Refractory Calcinosis in Systemic Sclerosis: A Single-Centre Observational Cohort Study
Systemic Sclerosis & Related Disorders – Clinical Poster III
9:00AM-11:00AM
Abstract Number: 1961
Mitochondrial DNA Sub-haplogroup H1 Influences the Risk of Rapidly Progressive Osteoarthritis of the Knee: Data from the Osteoarthritis Initiative
Genetics, Genomics & Proteomics Poster
9:00AM-11:00AM
Abstract Number: 2036
Mitochondrial DNA: A Potential Trigger of Cyclic GMP-AMP Synthase Activation in Systemic Lupus Erythematosus
SLE – Etiology & Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 2286
Mobile Responsive App – Useful Additional Tool for Data Collection in the German Pregnancy Register Rhekiss?
Reproductive Issues In Rheumatic Disorders Poster
9:00AM-11:00AM
Abstract Number: 2215
Modeling-Based Bone Formation Persists in the Femoral Neck Despite Remodeling Inhibition in Subjects Treated with Denosumab
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster
9:00AM-11:00AM
Abstract Number: 2376
Modifiable Factors Associated with Response to Treatment in Early Rheumatoid Arthritis
RA – Treatments Poster III: Safety and Outcomes
9:00AM-11:00AM
Abstract Number: 1937
Mononuclear Leukocyte DNA Methylome Imprinting of Networked Signaling and Immunity Regulatory Pathways in Gout
Genetics, Genomics & Proteomics Poster
9:00AM-11:00AM
Abstract Number: 2628
Mortality Predictors in ANCA-associated Vasculitis: Experience of a Brazilian Monocentric Cohort of a Rheumatology Center
Vasculitis – ANCA-Associated Poster I
9:00AM-11:00AM
Abstract Number: 2374
MRI of the Wrist in Early Rheumatoid Arthritis After 1-year Treat-to-target Strategy
RA – Treatments Poster III: Safety and Outcomes
9:00AM-11:00AM
Abstract Number: 2206
MRI-based Textural Analysis of Trabecular Bone: A Novel Method for the Opportunistic Screening of Bone Quality
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster
9:00AM-11:00AM
Abstract Number: 2185
MRI-detected Abnormalities in Prediction Models of Incident Radiographic Knee Osteoarthritis over 10 Years of Follow-up
Osteoarthritis – Clinical Poster II
9:00AM-11:00AM
Abstract Number: 2364
Multi-center Analyses on 518 Cases with Rheumatoid Arthritis Developing Lymphoproliferative Disorders (RA-LPD): The Prognostic Factors and the Influence of Anti-rheumatic Drugs on LPD Development
RA – Treatments Poster III: Safety and Outcomes
9:00AM-11:00AM
Abstract Number: 1935
Multi-Organ System Meta-Analytic Approach to Investigating Sarcoidosis
Genetics, Genomics & Proteomics Poster
9:00AM-11:00AM
Abstract Number: 2190
Multi-vendor Multi-site T1ρ and T2 Quantification of Knee Cartilage
Osteoarthritis – Clinical Poster II
9:00AM-11:00AM
Abstract Number: 2464
Multidisciplinary Unit of Psoriatic Arthritis: Clinical Results
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster III: Psoriatic Arthritis, Clinical Features
  • «Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 64
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology